INDBNK stock news
This page provides real-time market news, earnings updates, and company announcements related to Ind Bank Housing Ltd (INDBNK).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-11 16:38 IST
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
Finviz2026-04-01 13:03:53
Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Finviz2026-04-02 13:03:05
Janux Therapeutics Receives $35 Million Milestone Payment Through BMY Agreement
101 finance2026-04-02 19:33:59
Calidi Biotherapeutics (CLDI) Hinges on High-Stakes Q4 2026 IND Filing as Market Waits for Catalyst
101 finance2026-04-02 23:10:17
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 12:03:10
Immunome’s CEO purchases shares during a 250% surge—while the CSO offloads at the top, raising doubts among savvy investors
101 finance2026-04-04 17:48:47
Immunome (IMNM) Insider Executes Sale Under 10b5-1 Plan Ahead of FDA Filing—Has the Market Already Factored It In?
101 finance2026-04-04 23:45:37
Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026
Finviz2026-04-06 13:18:44
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
Finviz2026-04-07 11:48:47
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform's Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Finviz2026-04-07 12:03:49
Silo Pharma's Patent Win: A Flow Analysis of the 60% Surge
101 finance2026-04-07 13:27:49
Mesoblast’s Ryoncil Heads Into Crucial Adult Study—Investors Watch for Potential Tripling of Market Size
101 finance2026-04-08 03:10:02
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Finviz2026-04-08 10:03:59
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ in Pediatric Malignant Gliomas
Finviz2026-04-08 11:33:11
Kymera Therapeutics Announces Gilead Sciences' Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
Finviz2026-04-09 11:03:39
Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline
Finviz2026-04-09 12:39:08
Akari Therapeutics Participates in Virtual Investor "What This Means" Interview Discussing Strategic Partnership with WuXi XDC
Finviz2026-04-09 12:54:48
Steel Dynamics Announces First Quarter 2026 Earnings Conference Call and Webcast
Finviz2026-04-09 14:03:49
IVVD Surges on Pipeline Expansion, Hinges on $1.6124 Breakout
101 finance2026-04-09 15:45:40
Decoy Therapeutics: An AI-Powered Platform for Antiviral Solutions
101 finance2026-04-10 04:57:43
NeurAxis, Inc. Announces Preferred Stock Dividend
Finviz2026-04-10 11:03:13
KYMR Poised to Receive Milestone Payment Following GILD’s Acquisition of KT-200 License
101 finance2026-04-10 17:09:59
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 12:03:10
Immunome’s CEO purchases shares during a 250% surge—while the CSO offloads at the top, raising doubts among savvy investors
101 finance2026-04-04 17:48:47
Immunome (IMNM) Insider Executes Sale Under 10b5-1 Plan Ahead of FDA Filing—Has the Market Already Factored It In?
101 finance2026-04-04 23:45:37
Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026
Finviz2026-04-06 13:18:44
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
Finviz2026-04-07 11:48:47
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform's Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Finviz2026-04-07 12:03:49
Silo Pharma's Patent Win: A Flow Analysis of the 60% Surge
101 finance2026-04-07 13:27:49
Mesoblast’s Ryoncil Heads Into Crucial Adult Study—Investors Watch for Potential Tripling of Market Size
101 finance2026-04-08 03:10:02
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Finviz2026-04-08 10:03:59
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ in Pediatric Malignant Gliomas
Finviz2026-04-08 11:33:11
Kymera Therapeutics Announces Gilead Sciences' Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
Finviz2026-04-09 11:03:39
Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline
Finviz2026-04-09 12:39:08
Akari Therapeutics Participates in Virtual Investor "What This Means" Interview Discussing Strategic Partnership with WuXi XDC
Finviz2026-04-09 12:54:48
Steel Dynamics Announces First Quarter 2026 Earnings Conference Call and Webcast
Finviz2026-04-09 14:03:49
IVVD Surges on Pipeline Expansion, Hinges on $1.6124 Breakout
101 finance2026-04-09 15:45:40
Decoy Therapeutics: An AI-Powered Platform for Antiviral Solutions
101 finance2026-04-10 04:57:43
NeurAxis, Inc. Announces Preferred Stock Dividend
Finviz2026-04-10 11:03:13
KYMR Poised to Receive Milestone Payment Following GILD’s Acquisition of KT-200 License
101 finance2026-04-10 17:09:59
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
INDBNK stock price change
On the last trading day, INDBNK stock closed at 43.44 INR, with a price change of 0.74% for the day.
Trade stock perpsINDBNK stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more